Document ID: chunk:federal_register_of_legislation:F2024C00214:reg:9:p3
Version: federal_register_of_legislation:F2024C00214
Segment Type: reg
Provision Reference: reg 9 (pt 3/4)
Character Range: 10679–13694

of non-Hodgkin lymphoma;
            Note: ppm-years is defined in the Schedule 1 – Dictionary.
(22)      inhaling ethylene oxide vapour:
            (a)          for a cumulative total of at least 2 500 hours within a consecutive period of ten years before the clinical onset of non-Hodgkin lymphoma; and
            (b)          where the first exposure in that period occurred at least five years before the clinical onset of non-Hodgkin lymphoma;
(23)      being obese for at least five years within the 20 years before the clinical onset of non-Hodgkin lymphoma;
            Note: being obese is defined in the Schedule 1 – Dictionary.
(24)      having received a cumulative equivalent dose of at least 0.1 sievert of ionising radiation to the bone marrow at least five years before the clinical onset of non-Hodgkin lymphoma;
            Note: cumulative equivalent dose is defined in the Schedule 1 – Dictionary.
(25)      for diffuse large B-cell lymphoma only, having chronic inflammation as specified at the affected site for at least five years before the clinical onset of non-Hodgkin lymphoma;
            Note: chronic inflammation as specified is defined in the Schedule 1 – Dictionary.
(26)      for anaplastic large cell lymphoma of the breast only, having a breast implant at the time of the clinical onset of non-Hodgkin lymphoma;
(27)      inhaling, ingesting or having cutaneous contact with lindane on more days than not for a cumulative period of at least six months, at least five years before the clinical onset of non-Hodgkin lymphoma;
            Note: lindane is defined in the Schedule 1 – Dictionary.
(28)      inhaling, ingesting or having cutaneous contact with pentachlorophenol:
(a)          for a cumulative period of at least 1 000 hours, within a consecutive period of ten years, before the clinical onset of non‑Hodgkin lymphoma; and
(b)          where the first exposure occurred at least five years before the clinical onset of non-Hodgkin lymphoma;
(29)      inhaling, ingesting or having cutaneous contact with a chemical from the specified list:
(a)          for a cumulative period of at least 1 000 hours, within a consecutive period of ten years, before the clinical onset of non‑Hodgkin lymphoma; and
(b)          where the first exposure occurred at least five years before the clinical onset of non-Hodgkin lymphoma;
            Note: chemical from the specified list is defined in the Schedule 1 - Dictionary.
(30)      for T-cell lymphoma only, smoking at least ten pack-years of cigarettes, or the equivalent thereof in other tobacco products, before the clinical onset of non-Hodgkin lymphoma, and where smoking has ceased, the clinical onset of non-Hodgkin lymphoma has occurred within 20 years of cessation;
            Note: pack-years of cigarettes, or the equivalent thereof in other tobacco products is defined in the Schedule 1 – Dictionary.
(31)      having atopic dermatitis for at least two years before the clinical onset of non-Hodgkin lymphoma;
(32)